PHARMAZINNES
ActiveThe computed 12-month bankruptcy probability of PHARMAZINNES is 1.6% (moderate). The 2025 annual accounts show equity of €122k and a net result of €50k. Equity is growing by ~22.9% per year across the filed fiscal years. Its solvency ranks better than 24% of 10345 sector peers (fiscal year 2025). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
58
/ 100
Fair
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability76▲+3
Solvency39▲+6
Growth78=
Track record100
Bankruptcy probability, 12 months
1.6%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €7k at 30 days acceptable
Liquidity tight (current ratio 1.06 against 0.95 in 2024; short-term debt: 40.9% and cash: 19.1% of total assets), and 86.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Eight signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
13.9%
Return on assets
5.7%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 24% of 10345 sector peers (2025).
NBB · sector comparisonPosition among 10345 sector peers
Solvency
better than 24%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
on the day
2024
8 d late
2023
13 d late
2022
18 d early
2021
23 d early
2020
10 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€50k▲ 85.3%
2024 · €27k
2020: €1k
2021: €2k
2022: €27k
2023: €16k
2024: €27k
2020 → 2025
Working capital
€21k
2024 · €-17k
2020: €66k
2021: €58k
2022: €76k
2023: €-48k
2024: €-17k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€47k-€74k▲ 56.1%€46k▼ 37.7%€72k▲ 57.3%€122k▲ 68.5%
Operating result€7k-€35k▲ 380%€29k▼ 17.8%€44k▲ 50.9%€69k▲ 57.4%
Net result€2k-€27k▲ 1,555%€16k▼ 40.8%€27k▲ 68.0%€50k▲ 85.3%
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 57% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €875k
Fixed assets
€496k▼ 12.4%
Current assets
€379k▲ 15.1%
Equity and liabilities €875k
Equity
€122k▲ 68.5%
Debt
€754k▼ 8.5%
The debt ratio falls from 91.9% to 86.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€142k▲
2024 · €130k
Cash flow
€124k▲
2024 · €113k
Solvency
13.9%▲
2024 · 8.1%
Current ratio
1.06▲
2024 · 0.95
Quick ratio
0.68▲
2024 · 0.51
Debt / equity
6.19▼
2024 · 11.40
ROE
41.3%▲
2024 · 37.6%
ROA
5.7%▲
2024 · 3.0%
Interest coverage
29.64▲
2024 · 14.33
Debt
€754k▼
2024 · €823k
Debt ≤ 1 year
€358k▲
2024 · €346k
Debt > 1 year
€395k▼
2024 · €474k
Income taxes
€14k▲
2024 · €7k
Staff costs
€87k▲
2024 · €74k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€896k€875k▼
Fixed assets21/28€567k€496k▼
Intangible fixed assets21€285k€232k▼
Tangible fixed assets22/27€282k€265k▼
Land and buildings22€253k€242k▼
Plant, machinery and equipment23€12k€10k▼
Furniture and vehicles24€18k€13k▼
Current assets29/58€329k€379k▲
Stocks and contracts in progress3€152k€136k▼
Stocks30/36€152k€136k▼
Amounts receivable within one year40/41€66k€72k▲
Trade receivables40€55k€72k▲
Other amounts receivable41€11k€0▼
Cash at bank and in hand54/58€109k€167k▲
Deferred charges and accrued income490/1€2k€3k▲
Equity and liabilities
Total equity and liabilities10/49€896k€875k▼
Equity10/15€72k€122k▲
Contributions10/11€45k€45k=
Profit (loss) carried forward14€27k€77k▲
Amounts payable17/49€823k€754k▼
Amounts payable after more than one year17€474k€395k▼
Financial debts170/4€474k€395k▼
Amounts payable within one year42/48€346k€358k▲
Current portion of amounts payable after more than one year42€78k€78k▲
Trade debts44€63k€70k▲
Suppliers440/4€63k€70k▲
Taxes, remuneration and social security45€15k€17k▲
Taxes450/3€2k€5k▲
Remuneration and social security454/9€13k€12k▼
Other amounts payable47/48€190k€193k▲
Accrued charges and deferred income492/3€4k€0▼
Income statement
Code20242025
Remuneration, social security and pensions62€74k€87k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€86k€73k▼
Other operating charges640/8€3k€3k▼
Gross operating margin9900€207k€232k▲
Operating profit (loss)9901€44k€69k▲
Financial income75/76B€2€121▲
Recurring financial income75€2€121▲
Financial charges65/66B€9k€5k▼
Recurring financial charges65€9k€5k▼
Profit (loss) for the period before taxes9903€35k€64k▲
Income taxes67/77€7k€14k▲
Profit (loss) for the period9904€27k€50k▲
Profit (loss) for the period to be appropriated9905€27k€50k▲
Appropriation of the result
Profit (loss) to be appropriated9906€28k€78k▲
Profit (loss) brought forward from the previous period14P€918€27k▲
Profit to be distributed694/7€833€833=
Return on contributions (dividend)694€833€833=
Social balance
Average headcount (FTE)90871.31.5▲
The notes to these accounts (22 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2020net €50k ▲85.3%
Operating result €69k, net result €50k, both a record.
31-12
Financial
Equity above €100kEq €122k ▲68.5%
6 profitable years in a row build equity to €122k.
08-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 8 days late
2024
13-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 13 days late
2023
13-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
08-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
10-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 10 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Patenier 155000 NamurGround area
353 m²
Building footprint
66 m²
Volume, LiDAR
687 m³
Parcel 92302G0286/00Z003, Wallonia · tallest building 12.0 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
PHARMAZINNES
since 20192.294.137.201
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92302G0286/00Z003 | Wallonia | 353 m² | 1 · 66 m² | 12.0 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteNamur2.294.137.201
Similar companies · same sector, comparable size
Kapelle Apotheek
BE 0501.820.986
Aartselaar · Eq €122k
APOTHEEK TOLHUIS
BE 0413.595.528
Gent · Eq €122k
PHARMACIE SCHUBERT
BE 0447.095.269
Ukkel · Eq €122k
Global Pharma
BE 0769.932.847
Sint-Niklaas · Eq €122k
EUROPA APOTHEEK
BE 0827.020.614
Antwerpen · Eq €122k
Of 5,222 companies in sector 47730 we hold annual accounts for 3,861. 3,505 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-09-2019
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:pharmazinnes@outlook.be